Previous 10 | Next 10 |
Viela Bio, Inc. (VIE) Q1 2020 Earnings Conference Call May 13, 2020 17:00 ET Company Participants Mitchell Chan - Chief Financial Officer Bing Yao - Chairman & Chief Executive Officer Bill Ragatz - Vice President, Head of Commercial Jorn Drappa - Chief Medical Officer &...
VIELA BIO (NASDAQ: VIE ): Q1 GAAP EPS of -$0.80 misses by $0.10 . More news on: Viela Bio, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today reported financial results and provided program highlights for the first quarter ended Mar...
-Safety profile comparable to placebo control- -Potent depletion of plasmacytoid dendritic cells in peripheral blood and skin biopsies- -Dose-dependent improvements in Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) scores- GAITHERSBURG, Md., May 13, 2020...
GAITHERSBURG, Md., May 06, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, May 13, 2020 at...
GAITHERSBURG, Md., April 30, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the election of Rachelle Jacques to its Board of Directors. As a veteran of the bi...
Mersana Therapeutics (NASDAQ: MRSN ) initiated with Buy rating and $14 (50% upside) price target at BTIG Research. Shares up 2% premarket. More news on: Mersana Therapeutics, Inc., Viela Bio, Inc., Y-mAbs Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Rea...
Jazz Pharmaceuticals (NASDAQ: JAZZ ) initiated with Buy rating and $149 (51% upside) price target at Jefferies. More news on: Jazz Pharmaceuticals plc, Walgreens Boots Alliance, Inc., Acceleron Pharma Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Image source: The Motley Fool. Viela Bio Inc (NASDAQ: VIE) Q4 2019 Earnings Call Mar 25, 2020 , 5:00 p.m. ET Operator Continue reading
Viela Bio, Inc. (VIE) Q4 2019 Earnings Conference Call March 25, 2020 5:00 P.M. ET Company Participants Mitchell Chan - Chief Financial Officer Bing Yao - Chairman and Chief Executive Officer Jorn Drappa - Chief Medical Officer, Head of Research and Development Bill Ragatz - Vi...
News, Short Squeeze, Breakout and More Instantly...
> A three-year partnership that aligns with Veolia’s mission to support organizations and industries that want to become more environmentally sustainable > Veolia will start with focusing on improving waste collection, increasing recycling percentages, providing sustainable w...
Clean Earth will partner with Veolia North America on a five-year agreement to provide guaranteed incineration capacity in a new state-of-the-art waste treatment facility in Gum Springs, Ark. The agreement provides reliable, predictable, safe, and efficient waste disposal for Clean Ea...
The array will produce over 250 million kilowatt hours of electricity – enough to power 25,000 homes – and offset carbon output by 105,000 tons over the next 25 years, making it the only hazardous waste treatment facility in U.S. to be fully energy self-sufficient Veolia N...